Cardiovascular disease prevention and management in COVID-19: a clinical consensus statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging, the Association of Cardiovascular Nursing & Allied Professions, the European Association of Percutaneous Cardiovascular Interventions, and the Heart Failure Association of the ESC - Takeaways - MDSpire

Cardiovascular disease prevention and management in COVID-19: a clinical consensus statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging, the Association of Cardiovascular Nursing & Allied Professions, the European Association of Percutaneous Cardiovascular Interventions, and the Heart Failure Association of the ESC

  • By

  • Vassilios S Vassiliou

  • Vasiliki Tsampasian

  • Maria Luiza Luchian

  • Flavio D’Ascenzi

  • Fabrizio D’Ascenzo

  • Marc R Dweck

  • Javier Escaned

  • Sabiha Gati

  • Martin Halle

  • Konstantinos C Koskinas

  • Lis Neubeck

  • Michael Papadakis

  • Steffen E Petersen

  • Arsen Ristic

  • Marco Metra

  • Giuseppe Biondi-Zoccai

  • September 18, 2025

  • 0 min

Share

  • 1

    COVID-19 can exacerbate cardiovascular complications during both acute and post-acute phases, leading to long-term sequelae known as Long COVID.

  • 2

    Cardiac Long COVID includes symptoms such as angina, arrhythmias, and heart failure, affecting over 20% of Long COVID patients.

  • 3

    The consensus statement emphasizes tailored cardiovascular prevention strategies for patients with recent or prior COVID-19 infections.

  • 4

    Early cardiovascular prevention is crucial to mitigate risks like myocarditis and thrombosis following acute SARS-CoV-2 infection.

  • 5

    Ongoing research is essential to refine preventive measures and improve cardiovascular care in the context of COVID-19.

Original Source(s)

Cardiovascular disease prevention and management in COVID-19: a clinical consensus statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging, the Association of Cardiovascular Nursing & Allied Professions, the European Association of Percutaneous Cardiovascular Interventions, and the Heart Failure Association of the ESC

  • by Vassilios S Vassiliou, Vasiliki Tsampasian, Maria Luiza Luchian, Flavio D’Ascenzi, Fabrizio D’Ascenzo, Marc R Dweck, Javier Escaned, Sabiha Gati, Martin Halle, Konstantinos C Koskinas, Lis Neubeck, Michael Papadakis, Steffen E Petersen, Arsen Ristic, Marco Metra, Giuseppe Biondi-Zoccai

  • September 18, 2025

Related Content

Correction: Association between systemic immune-inflammation index(SII) and all-cause and cardiovascular mortality in heart failure patients: a single-center retrospective analysis

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Pulmonary vein stenosis after pediatric heart transplantation: incidence and risk factors